Host-Assisted Delivery of a Model Drug to Genomic DNA: Key Information from Ultrafast Spectroscopy and in silico Study

Chembiochem. 2022 May 4;23(9):e202200109. doi: 10.1002/cbic.202200109. Epub 2022 Mar 11.

Abstract

Drug delivery to a target without adverse effects is one of the major criteria for clinical use. Herein, we have made an attempt to explore the delivery efficacy of SDS surfactant in a monomer and micellar stage during the delivery of the model drug, Toluidine Blue (TB) from the micellar cavity to DNA. Molecular recognition of pre-micellar SDS encapsulated TB with DNA occurs at a rate constant of k1 ∼652 s-1 . However, no significant release of encapsulated TB at micellar concentration was observed within the experimental time frame. This originated from the higher binding affinity of TB towards the nano-cavity of SDS at micellar concentration which does not allow the delivery of TB from the nano-cavity of SDS micelles to DNA. Thus, molecular recognition controls the extent of DNA recognition by TB which in turn modulates the rate of delivery of TB from SDS in a concentration-dependent manner.

Keywords: DNA; drug delivery; micelles; pre-micelles; toluidine blue.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA*
  • Genomics
  • Micelles*
  • Spectrum Analysis
  • Surface-Active Agents

Substances

  • Micelles
  • Surface-Active Agents
  • DNA